B+
Bull case
25%
Probability
Target price
$49.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
GRDN
Guardian Pharmacy ServicesCNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
55%
Probability
Target price
$43.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$33.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-09-03
Recent news sentiment (30D)
+0.7
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
-
Unavailable
Sentiment proxy
+58.9
Score
AI commentary
Recent news tone is positive because of the Q2 results, raised guidance, and expansion updates. However, the packet does not provide social coverage, options data, short interest, employee sentiment, post-print price reaction, or analyst revisions; those gaps reduce confidence. This is a constructive but monitoring-oriented view.
RankAlpha Sentiment Codex - 2026-09-03
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-06eventQ2 execution and raised FY2026 guidanceMedium impact
Guardian reported Q2 revenue of $351.8 million, adjusted EBITDA of $29.7 million, and residents served up 8% year over year. Management raised FY2026 revenue guidance to $1.43-$1.45 billion and adjusted EBITDA guidance to $129-$131 million. [#SEC-8K-2026-08-06]
2026-12-02catalystIRA-related reimbursement pressureHigh impact
IRA-related pricing reductions limited reported revenue growth to 2% year over year, although management said underlying growth would have been low double digits absent those reductions. Continued reimbursement pressure remains a near-term execution risk. [#SEC-8K-2026-08-06]
2027-09-03catalystScale and geographic expansionHigh impact
The company cited scale, purchasing leverage, operating efficiency, continued local-market momentum, the Wellness Concepts acquisition, and a new Lexington, Kentucky greenfield pharmacy as growth supports. [#SEC-8K-2026-08-06]
Recommendation
N/A
No formal recommendation provided.
As of 2026-09-03 • Updated nightlySource: Internal modelMethodology